OHSU awarded $7.5 million to advance gene therapy for kidney diseases
October 08, 2026
Nakai lab receives three NIH grants to develop potential curative treatments for inherited kidney diseases.
Stories
El ‘Doc’ está de turno: Perro de asistencia brinda consuelo a pacientes de cáncer
October 06, 2026
‘Es un buen chico. Y llena de alegría a las personas’: La colaboración con Assistance Dogs Northwest se amplía al Instituto Oncológico Knight (Knight Cancer Institute).
The ‘Doc’ is in: Assistance dog provides comfort to patients with cancer
October 06, 2026
‘He’s a good boy. And he brings people joy’: Partnership with Assistance Dogs Northwest expands to Knight Cancer Institute.
OHSU utiliza la medicina bioelectrónica en el nervio vago para favorecer la recuperación de pacientes con accidentes cerebrovasculares y artritis
October 01, 2026
Un neurocirujano realiza por primera vez en Oregón implantes de dispositivos que emiten pequeños impulsos eléctricos para estimular la recuperación y producir un efecto antiinflamatorio.
OHSU uses bioelectric medicine in vagus nerve to help patients heal from stroke, arthritis
October 01, 2026
Neurosurgeons are first in Oregon to implant devices that send small electrical pulses to stimulate healing, anti-inflammatory effect.
OHSU obtiene $4.6 millones para ampliar los ensayos clínicos en comunidades rurales marginadas
September 30, 2026
Las nuevas adjudicaciones de CARE for Health™ llevarán estudios sobre salud materna y dolor crónico a clínicas rurales de todo el Noroeste.
OHSU secures $4.6 million to expand clinical trials in underserved rural communities
September 30, 2026
New CARE for Health™ awards will bring maternal health, chronic pain studies to rural clinics across the Northwest.
OHSU inscribe a su primer participante de la Costa Oeste en un ensayo de edición genética por colesterol alto
September 29, 2026
Una infusión puntual con CRISPR puede reducir permanentemente el colesterol LDL, disminuyendo el riesgo de infarto o accidente cerebrovascular.
OHSU enrolls first West Coast participant in gene-editing trial for high cholesterol
September 29, 2026
One-time infusion using CRISPR may permanently lower LDL cholesterol, reducing the risk of heart attack, stroke.
New board of directors, executive leadership team signal ambitious momentum for OHSU Knight Cancer Institute
September 24, 2026
Healthcare visionaries, business leaders, philanthropist, innovators from across the country will help govern and lead.
